| Date | Company Name | Action | Current
Price | Price
Target | Rating |
|---|
| 12/3/2025 | OCS Oculis | Initiated Coverage | $20.00 | $55.00 | Outperform |
| 12/2/2025 | UPB Upstream Bio | Initiated Coverage | $28.00 | $43.00 | Outperform |
| 12/1/2025 | IKT Inhibikase Therapeutics | Upgrade | $2.00 | | Strong-Buy |
| 11/14/2025 | ADAG Adagene | Upgrade | $2.00 | | Strong-Buy |
| 11/13/2025 | SRZN Surrozen | Upgrade | $18.00 | | Strong-Buy |
| 11/13/2025 | MRSN Mersana Therapeutics | Downgrade | $27.00 | | Strong-Buy ➝ Hold |
| 11/12/2025 | ATXS Astria Therapeutics | Downgrade | $13.00 | | Strong-Buy ➝ Hold |
| 10/27/2025 | AMLX Amylyx Pharmaceuticals | Upgrade | $14.00 | | Strong-Buy |
| 10/23/2025 | KOD Kodiak Sciences | Initiated Coverage | $25.00 | $40.00 | Outperform |
| 10/22/2025 | AVDL Avadel Pharmaceuticals | Downgrade | $21.00 | | Strong-Buy ➝ Hold |
| 10/21/2025 | CADL Candel Therapeutics | Initiated Coverage | $5.00 | $16.00 | Outperform |
| 10/14/2025 | SVRA Savara | Upgrade | $6.00 | | Strong-Buy |
| 10/14/2025 | MNMD Mind Medicine (MindMed) | Upgrade | $12.00 | | Strong-Buy |
| 10/14/2025 | DYN Dyne Therapeutics | Upgrade | $21.00 | | Strong-Buy |
| 10/9/2025 | AKRO Akero Therapeutics | Downgrade | $55.00 | | Strong-Buy ➝ Hold |
| 10/6/2025 | CMPX Compass Therapeutics | Initiated Coverage | $6.00 | $10.00 | Outperform |
| 9/30/2025 | MRUS Merus | Reiterated Rating | $96.00 | $97.00 | Outperform ➝ Market Perform |
| 9/29/2025 | KALA KALA BIO | Downgrade | $1.00 | | Strong-Buy ➝ Hold |
| 9/29/2025 | MRUS Merus | Downgrade | $96.00 | | Strong-Buy ➝ Hold |
| 9/10/2025 | SLNO Soleno Therapeutics | Upgrade | $53.00 | | Strong-Buy |
| 9/9/2025 | TRML Tourmaline Bio | Downgrade | $48.00 | $48.00 | Outperform ➝ Hold |
| 9/8/2025 | GPCR Structure Therapeutics | Upgrade | $33.00 | | Strong-Buy |
| 9/3/2025 | AQST Aquestive Therapeutics | Upgrade | $6.00 | | Strong-Buy |
| 9/3/2025 | AVDL Avadel Pharmaceuticals | Upgrade | $21.00 | | Strong-Buy |
| 9/3/2025 | KALA KALA BIO | Upgrade | $1.00 | | Strong-Buy |
| 9/3/2025 | CNTA Centessa Pharmaceuticals | Upgrade | $30.00 | | Strong-Buy |
| 9/3/2025 | PRAX Praxis Precision Medicines | Upgrade | $190.00 | | Strong-Buy |
| 8/18/2025 | RVMD Revolution Medicines | Initiated Coverage | $78.00 | $80.00 | Outperform |
| 8/4/2025 | PVLA Palvella Therapeutics | Initiated Coverage | $94.00 | $90.00 | Outperform |
| 7/30/2025 | VYNE VYNE Therapeutics | Downgrade | $0.00 | | Strong-Buy ➝ Hold |
| 7/23/2025 | ABVX Abivax | Boost Price Target | $111.00 | $45.00 ➝ $101.00 | Outperform ➝ Outperform |
| 7/22/2025 | RAPT Rapt Therapeutics | Upgrade | $34.00 | $31.00 | Strong-Buy |
| 7/12/2025 | CATX Perspective Therapeutics | Upgrade | $2.00 | | Strong-Buy |
| 7/12/2025 | CRBP Corbus Pharmaceuticals | Upgrade | $11.00 | | Strong-Buy |
| 6/26/2025 | DBVT DBV Technologies | Upgrade | $13.00 | | Strong-Buy |
| 6/18/2025 | CBIO Crescent Biopharma | Upgrade | $13.00 | $22.00 | Strong-Buy |
| 6/6/2025 | TECX Tectonic Therapeutic | Initiated Coverage | $21.00 | $87.00 | Outperform |
| 6/5/2025 | TECX Tectonic Therapeutic | Upgrade | $21.00 | | Strong-Buy |
| 6/3/2025 | SRRK Scholar Rock | Upgrade | $45.00 | | Strong-Buy |
| 3/12/2025 | GLUE Monte Rosa Therapeutics | Initiated Coverage | $17.00 | $19.00 | Outperform |
| 3/11/2025 | TARA Protara Therapeutics | Initiated Coverage | $7.00 | $22.00 | Outperform |
| 3/11/2025 | MOLN Molecular Partners | Initiated Coverage | $4.00 | $12.00 | Outperform |
| 3/11/2025 | IMNM Immunome | Initiated Coverage | $20.00 | $20.00 | Outperform |
| 3/11/2025 | ZYME Zymeworks | Initiated Coverage | $27.00 | $30.00 | Outperform |
| 3/6/2025 | CATX Perspective Therapeutics | Upgrade | $2.00 | | Strong-Buy |
| 2/24/2025 | TRML Tourmaline Bio | Initiated Coverage | $48.00 | $58.00 | Outperform |
| 2/4/2025 | SLNO Soleno Therapeutics | Upgrade | $53.00 | | Strong-Buy |
| 1/31/2025 | AURA Aura Biosciences | Upgrade | $6.00 | | Strong-Buy |
| 12/27/2024 | JANX Janux Therapeutics | Upgrade | $16.00 | | Strong-Buy |
| 12/24/2024 | MREO Mereo BioPharma Group | Initiated Coverage | $2.00 | $10.00 | Outperform |
| 12/23/2024 | MREO Mereo BioPharma Group | Upgrade | $2.00 | | Strong-Buy |
| 12/13/2024 | RPTX Repare Therapeutics | Reiterated Rating | $2.00 | | Outperform ➝ Market Perform |
| 10/22/2024 | KURA Kura Oncology | Upgrade | $12.00 | | Strong-Buy |
| 10/10/2024 | OKUR OnKure Therapeutics | Upgrade | $3.00 | | Strong-Buy |
| 10/3/2024 | LQDA Liquidia | Initiated Coverage | $34.00 | $30.00 | Outperform |
| 10/2/2024 | LQDA Liquidia | Upgrade | $34.00 | | Strong-Buy |
| 9/16/2024 | ORKA Oruka Therapeutics | Initiated Coverage | $31.00 | $41.00 | Outperform |
| 9/9/2024 | AURA Aura Biosciences | Upgrade | $6.00 | | Strong-Buy |
| 8/26/2024 | CELC Celcuity | Initiated Coverage | $106.00 | $27.00 | Outperform |
| 8/21/2024 | CRBP Corbus Pharmaceuticals | Upgrade | $11.00 | | Strong-Buy |
| 7/31/2024 | ALXO ALX Oncology | Downgrade | $1.00 | | Strong-Buy ➝ Hold |
| 7/29/2024 | MRSN Mersana Therapeutics | Upgrade | $27.00 | | Strong-Buy |
| 7/29/2024 | RPTX Repare Therapeutics | Upgrade | $2.00 | | Strong-Buy |
| 7/29/2024 | IDYA IDEAYA Biosciences | Upgrade | $36.00 | | Strong-Buy |
| 7/29/2024 | MRUS Merus | Upgrade | $96.00 | | Strong-Buy |
| 7/29/2024 | NUVL Nuvalent | Upgrade | $107.00 | | Strong-Buy |
| 6/11/2024 | DNTH Dianthus Therapeutics | Upgrade | $45.00 | | Strong-Buy |
| 5/28/2024 | CALT Calliditas Therapeutics AB (publ) | Downgrade | $40.00 | | Strong-Buy ➝ Hold |
| 5/6/2024 | CATX Perspective Therapeutics | Reiterated Rating | $2.00 | | Outperform |
| 3/26/2024 | MLYS Mineralys Therapeutics | Reiterated Rating | $39.00 | | Outperform |
| 2/28/2024 | VTYX Ventyx Biosciences | Upgrade | $8.00 | | Market Perform ➝ Outperform |
| 2/27/2024 | GPCR Structure Therapeutics | Reiterated Rating | $33.00 | | Outperform |
| 2/20/2024 | LRMR Larimar Therapeutics | Reiterated Rating | $4.00 | | Outperform |
| 1/23/2024 | INBX Inhibrx Biosciences | Downgrade | $87.00 | | Outperform ➝ Market Perform |
| 1/5/2024 | IVA Inventiva | Reiterated Rating | $4.00 | | Outperform |
| 12/26/2023 | TARS Tarsus Pharmaceuticals | Reiterated Rating | $82.00 | | Outperform |
| 12/26/2023 | RCKT Rocket Pharmaceuticals | Reiterated Rating | $3.00 | | Outperform |
| 12/4/2023 | SYRE Spyre Therapeutics | Reiterated Rating | $34.00 | | Outperform |
| 11/27/2023 | TCRX TScan Therapeutics | Reiterated Rating | $1.00 | | Outperform |
| 11/7/2023 | VTYX Ventyx Biosciences | Downgrade | $8.00 | | Outperform ➝ Market Perform |
| 8/8/2023 | TNYA Tenaya Therapeutics | Reiterated Rating | $1.00 | | Outperform |
| 8/8/2023 | INBX Inhibrx Biosciences | Reiterated Rating | $87.00 | | Outperform |
| 4/26/2023 | PYXS Pyxis Oncology | Reiterated Rating | $4.00 | | Outperform |
| 4/26/2023 | OLMA Olema Pharmaceuticals | Reiterated Rating | $28.00 | | Outperform |
| 4/26/2023 | ALXO ALX Oncology | Reiterated Rating | $1.00 | | Outperform |
| 4/26/2023 | AVDL Avadel Pharmaceuticals | Reiterated Rating | $21.00 | | Outperform |
| 4/26/2023 | INBX Inhibrx Biosciences | Reiterated Rating | $87.00 | | Outperform |
| 4/24/2023 | IRON Disc Medicine | Reiterated Rating | $94.00 | | Outperform |
| 4/11/2023 | AKRO Akero Therapeutics | Reiterated Rating | $55.00 | | Outperform |
| 4/5/2023 | IFRX InflaRx | Upgrade | $1.00 | | Market Perform ➝ Outperform |
| 3/27/2023 | CRNX Crinetics Pharmaceuticals | Reiterated Rating | $47.00 | | Outperform |
| 3/8/2023 | OBIO Orchestra BioMed | Reiterated Rating | $5.00 | | Outperform |
| 3/7/2023 | ELVN Enliven Therapeutics | Reiterated Rating | $21.00 | | Outperform |
| 12/21/2022 | MLTX MoonLake Immunotherapeutics | Reiterated Rating | $15.00 | | Outperform |
